EBUS-TBNA对已治疗头颈癌患者胸腔内转移的诊断与预后价值
回顾性分析75例既往接受头颈癌治疗、因疑似胸腔内转移行EBUS-TBNA的患者,共取样126个病灶。EBUS-TBNA诊断转移性头颈癌的敏感度88.2%、特异度100.0%、阳性预测值100.0%、阴性预测值80%、诊断准确率92.0%。EBUS-TBNA检出胸腔内转移与总生存期不良预后相关(P = .008),且为独立预后因素。
要点
- EBUS-TBNA诊断转移性头颈癌敏感度88.2%、特异度100.0%、准确率92.0%,阴性预测值80%。
- 75例疑似胸腔内转移患者中发现6例假阴性。
- EBUS-TBNA检出转移与总生存期不良预后相关(P = .008),为独立预后因素。
核心结论
- EBUS-TBNA是评估头颈癌治疗后疑似胸腔内转移的安全、有效、微创方法,检出的胸腔内转移对既往治疗的头颈癌患者具有重要预后意义。
研究设计与样本
- 回顾性分析2012年3月至2021年12月间75例有头颈癌治疗史、因疑似胸腔内转移行EBUS-TBNA的患者,共取样126个靶病灶(107个纵隔/肺门淋巴结和19个肺内/纵隔肿块)。
诊断标准与关键数值
- EBUS-TBNA诊断转移性头颈癌的敏感度为88.2%、特异度为100.0%、阳性预测值为100.0%、阴性预测值为80%、诊断准确率为92.0%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The present study assessed the diagnostic and prognostic significance of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for suspected intrathoracic metastasis after HNC treatment.
METHODS: A retrospective analysis was conducted on 75 patients with a prior history of head and neck cancer treatment who underwent EBUS-TBNA for suspected intrathoracic metastases between March 2012 and December 2021.
RESULTS: A total of 126 targeted lesions, including 107 mediastinal/hilar lymph nodes and 19 intrapulmonary/mediastinal masses, were sampled. The metastatic head and neck cancer (HNC) cases detected by EBUS-TBNA consisted of nasopharyngeal carcinoma (n = 24), oropharyngeal carcinoma (n = 3), hypopharynx carcinoma (n = 6), laryngeal carcinoma (n = 6), and oral cavity carcinoma (n = 6). Cases with negative EBUS-TBNA results consisted of tuberculosis (n = 9), sarcoidosis (n = 3), anthracosis (n = 9), and reactive lymphadenitis (n = 9). Six false-negative cases were found among the 75 patients with suspected intrathoracic metastases. The diagnostic sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of the EBUS-TBNA procedure for metastatic HNC were 88.2, 100.0, 100.0, 80, and 92.0%, respectively. The diagnosis of HNC intrathoracic metastasis by EBUS-TBNA correlated with an adverse prognosis in terms of overall survival (OS) (P = .008). The log-rank univariate analysis and Cox regression multivariate analysis results indicated that the detection of metastatic HNC through EBUS-TBNA was a significant independent prognostic factor for patients with HNC who had received prior treatment.
CONCLUSIONS: Endobronchial ultrasound-guided transbronchial needle aspiration is a safe, effective, and minimally invasive procedure for assessing suspected intrathoracic metastasis in HNC patients after treatment. The intrathoracic metastasis detected by EBUS-TBNA has crucial prognostic significance in previously treated HNC patients.
引用
- Li SP, Zhang ZM, Bao Y, et al. The Diagnostic and Prognostic Value of EBUS-TBNA for Intrathoracic Metastasis in Previously Treated Patients With Head and Neck Cancer. J Ultrasound Med. 2023. PMID: 37449666. doi:10.1002/jum.16302
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。